| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Xanadu completes SPAC merger, to begin trading Thursday | ||
| Do | Wolfspeed closes $476M debt refinancing transaction | ||
| Do | BARK approves 1-for-20 reverse stock split to regain NYSE compliance | ||
| Do | Crinetics submits application for acromegaly drug in Brazil | ||
| Do | Shuttle Pharma expands AI drug discovery platform capabilities | ||
| Do | Crown Holdings appoints John Rost as COO for Asia Pacific | ||
| Do | Shield AI raises $2B, buys Aechelon for simulation tech | ||
| Do | Canaccord reiterates Lovesac stock rating on product innovation | ||
| Do | DA Davidson maintains Lovesac stock rating on product innovation | ||
| Do | GLJ Research cuts Sunrun stock price target on industry concerns | ||
| Do | BNP Paribas Exane raises Salesforce stock price target to $230 | ||
| Do | Leerink reiterates Rhythm Pharmaceuticals stock rating on CHMP opinion | ||
| Do | Leerink reiterates Outperform on iBio stock amid competitor data | ||
| Do | Leerink cuts Wave Life Sciences stock price target on obesity drug data | ||
| Do | Boring Co. sought Houston tunnel project to ease traffic - Bloomberg | ||
| Do | Jefferies reiterates Buy on United Airlines stock after labor deal | ||
| Do | Arrowhead Pharma stock rating reiterated at Buy by TD Cowen | ||
| Do | Warren Davidson of Ohio's 8th district sells shares in GE Healthcare Technologies | ||
| Do | Sunrun stock price target cut to $4.63 by GLJ Research on survival concerns | ||
| Do | Mizuho reiterates SoFi stock rating on new loan partnerships | ||
| Do | Goldman Sachs reiterates SoFi stock Neutral rating on loan platform expansion | ||
| Do | Evercore sees more insurance coverage disputes after court ruling | ||
| Do | Jefferies cuts WAVE Life Sciences price target to $18 on obesity data | ||
| Do | Cegedim FY 2025 slides: profit surges 25% on cost discipline | ||
| Do | Freedom Capital Markets initiates Otter Tail stock with Hold rating |